Gregory C. Bowen - 19 May 2025 Form 3 Insider Report for Dorman Products, Inc. (DORM)

Role
VP, Chief Accounting Officer
Signature
/s/ Frank J. Mahr, by Power of Attorney
Issuer symbol
DORM
Transactions as of
19 May 2025
Net transactions value
$0
Form type
3
Filing time
23 May 2025, 16:37:33 UTC
Next filing
04 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bowen Gregory C. VP, Chief Accounting Officer C/O DORMAN PRODUCTS, INC., 3400 EAST WALNUT STREET, COLMAR /s/ Frank J. Mahr, by Power of Attorney 23 May 2025 0002068014

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DORM Common Stock 3,867 19 May 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DORM Employee Stock Option (right to buy) 19 May 2025 Common Stock 1,453 $101.45 Direct F2
holding DORM Employee Stock Option (right to buy) 19 May 2025 Common Stock 1,974 $96.36 Direct F3
holding DORM Employee Stock Option (right to buy) 19 May 2025 Common Stock 2,077 $91.28 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of (1) 1,742.9296 shares of common stock and (2) 2,124 unvested restricted stock units representing contingent rights to receive shares of Dorman common stock. The unvested restricted stock units will vest: (i) as to 167 shares on March 2, 2026, which is the fourth anniversary of their date of grant; (ii) as to 410 shares, in two equal annual installments beginning on March 2, 2026, which is the third anniversary of their date of grant; (iii) as to 750 shares, in two equal annual installments beginning on March 4, 2026, which is the second anniversary of their date of grant; and (iv) as to 797 shares, in three equal annual installments beginning on March 3, 2026, which is the first anniversary of their date of grant.
F2 The option vests in four equal annual installments beginning on March 2, 2022, which was the first anniversary of the date of grant.
F3 The option vests in four equal annual installments beginning on March 2, 2023, which was the first anniversary of the date of grant.
F4 The option vests in four equal annual installments beginning on March 2, 2024, which was the first anniversary of the date of grant.

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.